Myiasis, an infestation of fly larvae, was first described in 1840. The larvae are deposited as eggs into living mammals where they feed and complete their life cycle.[@b1-asm-3-208] The clinical findings of myiasis vary according to the fly species, the number of larvae and the location of the invaded area. The most common type of myiasis involves the skin. Cutaneous myiasis can manifest as furuncular, inflamed skin, wounded skin, myiasis linearis (larvae migrans) and traumatic myiasis. Myiasis in diabetic patients falls into the wounded skin group. In this group, myiasis can be caused by the larvae of *Cochliomyia hominivorax*, *Chrysomya bezziana, Lucilia sericata*, *Phormia regina, Sarcophaga, Calliphora* and *Stomoxys*.[@b2-asm-3-208],[@b3-asm-3-208] Wound myiasis often occurs as an infestation of a wound with fly larvae. In neglected and mistreated wounds, the first stage larvae initially penetrate into the exfoliating part and go deeper, initially damaging the tissue.[@b1-asm-3-208],[@b3-asm-3-208] The incidence of myiasis increases in elderly patients living in conditions of poor environmental hygiene and of low socioeconomic status, with mental retardation, diabetes and vascular problems. Myiasis is especially common but not strictly confined to the tropics..[@b1-asm-3-208],[@b2-asm-3-208],[@b4-asm-3-208] Although diabetes mellitus is a risk factor for myiasis, diabetic foot is quite rare among myiasis cases.[@b5-asm-3-208],[@b6-asm-3-208] This observational retrospective study was designed to identify the characteristics of myiasis in patients with diabetic foot.

PATIENTS AND METHODS
====================

Cases with diabetic foot infection complicated by myiasis that were admitted to the Diabetic Foot Council of Ege University and/or the Diabetic Foot Clinic of Buca SD State Hospital between June 2012 and July 2017 were included in the study. We recorded patient age, gender, duration of diabetes, coexisting bacterial infections on the wound site, infectious agents causing infestations, socioeconomic status, presence of mental retardation, confinement to bed and additional comorbid diseases. The necessity for amputation, presence of necrosis, and presence of sepsis were recorded.[@b7-asm-3-208] Polymicrobial infection was recorded in cases of a positive culture of a sample of the abscess, bone, tissue or blood with two or more different microorganisms at the same time.[@b8-asm-3-208],[@b9-asm-3-208]

In all cases, larval debridement therapy was performed at the bedside in consecutive sessions. The entire wound was cleaned with 10% polyvinyl chloride-iodine. After a minute, all larvae were collected one by one with sterile tweezers ([Figure 1](#f1-asm-3-208){ref-type="fig"}). Lastly, the wounds were covered with sterile dressings. This method was repeated daily. After larval debridement therapy, the wounds were washed with saline, and superficial necrotic tissues were debrided. Deep infected tissues were collected using another sterile surgical blade and sterile tissue scissors. These deep tissue samples were used for bacterial and fungal cultures. Both larvae and tissue samples were placed in a sterile container and quickly delivered to the laboratory. Macroscopic and microscopic examinations of the debrided larvae were performed. In addition, species were identified by distinctive morphological features such as the state of peritreme, and by identification of stigmata ([Figure 2](#f2-asm-3-208){ref-type="fig"}).[@b10-asm-3-208]

During admission, all cases (or their relatives) were informed and signed the informed consent form. During the first larval debridement therapy, a video was filmed to record the characteristics of the larvae (**Online Resource 1**). The patients were reported using the guidelines of the PROCESS Statement.[@b11-asm-3-208]

RESULTS
=======

Eighteen cases of diabetic foot infections complicated by myiasis were included in the study. Eight (44.4 %) of the cases were female. According to the Infectious Diseases Society of America score, ten (55.6%) were severe, six (33.4%) moderate and two (11.1%) were mild diabetic foot infections. In all cases, larval debridement treatment was performed at the bedside in consecutive sessions. All the wounds were cleaned of larvae on the second day. However, the wounds of the 11th and 14th patients were completed on the third day (11.1%) ([Table 1](#t1-asm-3-208){ref-type="table"}). The wounds of all cases were followed up for at least four days. Larval structures were examined macroscopically and microscopically, and a third stage larva of *Calliphora* was detected in one case (5.56%). In five (27.8%) patients, a second stage *Lucilia sericata* larva-was found, and in seven (38.9%) patients, a third stage *Lucilia sericata* larva was found. Because of inappropriate transport conditions, the stage of the larva was not identified correctly in five cases (27.8%). Myiasis was more frequent in the months of May, June and July.

Fourteen (77.8%) patients underwent surgery: four (22.2%) received below-knee amputations, four (22.2%) had metatarsophalangeal joint disarticulations, three (16.7%) ray amputations, two (11.1%) deep surgical debridement therapies, and one (5.56%) a syme amputation. Four (22.2%) of the patients could not undergo major surgery. Two (11.1%) of these cases refused amputation treatment after myiasis debridement therapy and were discharged upon their request. The other two (11.1%) died before surgery. One (5.56%) patient died within 48 hours after surgery. All patients had bacterial infections with myiasis. Wound cultures were taken from all as shown in [Table 1](#t1-asm-3-208){ref-type="table"}. In seven (38.9%) patients who had no bacterial growth, we detected leukocytosis and left shift accompanied by edema or discharge around the wound.

DISCUSSION
==========

Diabetic foot infections (DFIs) rarely include fungal infections, but when they do amputation rates are increased by ten times.[@b8-asm-3-208] Even if fungal DFIs are rare, their presence cannot be neglected since it may be a prognostic factor in DFIs. Findings in myiasis vary depending on the affected body region. Among our patients with DFI, myiasis was frequently seen in the months of May, June and July, but myiasis is often seen in rural areas in autumn and summer.[@b1-asm-3-208] Myiasis can cause psychological disorders due to functional health problems and appearance.[@b1-asm-3-208],[@b6-asm-3-208] Although not a tropical climate zone like Africa and America, Turkey is at risk for myiasis, which could be endemic due to reasons such as a high population in rural areas and animal husbandry.[@b6-asm-3-208],[@b12-asm-3-208],[@b13-asm-3-208]

Foot, wound and skin care is an essential practice that needs to be performed carefully and systematically in patients with chronic wounds such as diabetic foot ulcers. The probability of developing neuropathy for all diabetic diseases is 30% to 50%.[@b14-asm-3-208] The most common type of neuropathy is distal symmetrical polyneuropathy that can cause serious sensory loss in the affected areas. Diabetic polyneuropathy is the major cause of amputation with infection and ischemia.[@b15-asm-3-208] This makes patients with myiasis infestation feel little or no pain. Thus, it is difficult to be aware of the situation and take precautions. This is also the reason why diabetic foot ulcers are high-risk ulcers for myiasis. The risk is also high in paralyzed patients who are bedridden and unable to care for themselves,[@b1-asm-3-208],[@b2-asm-3-208],[@b4-asm-3-208],[@b6-asm-3-208] which is why the wounds should not be left open for a long time in patients with these conditions. The wound site may need to be aerated to avoid conditions like maceration. If the wound is left open for aeration, it must be covered with a thin layer of sterile gauze. The pores of the gauze must be small enough to prevent flies from penetrating while allowing airflow. In addition, chronic wounds should be treated at least once a day and should be closed well.[@b16-asm-3-208] The wound site should be inspected and cleaned regularly, so that formation of myiasis again is less likely.

The recommended treatment of myiasis is to collect all visible larvae and screwworms directly from the wound and to perform active debridement and daily dressing with antiseptic solutions; if possible, the infested area should be removed completely.[@b17-asm-3-208],[@b18-asm-3-208] If necessary, excisions can also be made to reach the larvae.[@b12-asm-3-208] First, larvae and eggs are forced to the surface by triggering regional hypoxia with a toxic substance; then, the larvae on the surface are mechanically cleaned.[@b2-asm-3-208],[@b19-asm-3-208] These procedures are the only active treatment protocols.[@b20-asm-3-208] The most important recommendation is related to the prevention of myiasis. Therefore, the care and protection of chronic and untreated wounds is highly important.[@b20-asm-3-208]

In our study, active sequential debridement was applied to all patients. By sequential debridement of the wound site, we aimed to find all multi-stage larvae, which might have been overlooked and subsequently matured. Skin myiasis patients have been reported as "rare cases" since 2000. Three cases reported from Germany involved elderly and alcohol-dependent patients of low socioeconomic status and/or with diabetes mellitus, which constitute a high-risk group.[@b21-asm-3-208] A case of *Sarcophaga* in diabetics was reported from Saudi Arabia[@b16-asm-3-208] and a similar case was reported from Italy.[@b22-asm-3-208] In addition, a notable case was reported from Turkey.[@b6-asm-3-208] A case from Argentina reported larvae of the Calliphoridae family, which we also found in one of our patients.[@b23-asm-3-208]

Samples taken from the wounds of myiasis patients should be sent to the nearest parasitology laboratory of a training and research or university hospital.[@b21-asm-3-208] In this study, the larval specimens taken from the patients were studied in the Direct Diagnosis Laboratory in the Department of Parasitology at University Medical Faculty, Ege University. In addition, early admission to a tertiary care hospital improves the prognosis due to the experienced diabetic foot consultants located in these centers. This is also true for cases of diabetic foot complicated by myiasis.[@b24-asm-3-208]

In conclusion, myiasis has only been reported in single case reports in patients with diabetic foot infection. To the best of our knowledge, our study presents the largest series of myiasis cases in the literature. The increased incidence of myiasis in Turkey could be due to the self-care deficit in diabetic patients.[@b25-asm-3-208]
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![Larvae were collected with a sterile surgical tweezers.](asm-3-208f1){#f1-asm-3-208}

![Larvae were identified macro- and microscopically.](asm-3-208f2){#f2-asm-3-208}

###### 

Demographic and clinical features of the cases.

  No   Age (years)   Gender   DM duration (years)   Wound duration (days)   Necrosis   Sepsis   PEDIS-IDSA infection score   Addition diseases   Confined to bed   Living in nursing home   Homeless or living alone   Poor hygienic conditions   Bacterial growth in tissue culture                            Date of infestation (month)
  ---- ------------- -------- --------------------- ----------------------- ---------- -------- ---------------------------- ------------------- ----------------- ------------------------ -------------------------- -------------------------- ------------------------------------------------------------- -----------------------------
  1    87            Female   30                    15                      Yes        Yes      Severe                       Alzheimer           Yes               Yes                      No                         Yes                        *Acinetobacter baumannii*                                     August 2014
  2    64            Female   13                    60                      No         Yes      Severe                       CVE                 Yes               No                       No                         Yes                        *Pseudomonas aeruginosa*                                      June 2013
  3    67            Male     12                    40                      Yes        Yes      Severe                       CRF, HT             No                No                       No                         Yes                        *Serratia liquefaciens, Escherichia coli*                     February 2013
  4    74            Male     25                    180                     No         No       Moderate                     --                  No                No                       No                         Yes                        Negative                                                      July 2013
  5    48            Male     15                    180                     Yes        No       Moderate                     CRF, HT             No                No                       Yes                        No                         Negative                                                      June 2013
  6    83            Female   27                    30                      Yes        Yes      Severe                       HT, Alzheimer       No                Yes                      No                         No                         *Klebsiella oxytoca, Enterobacter aerogenes*                  March 2016
  7    62            Male     10                    150                     No         No       Moderate                     RA, HT, CVE, PAD    No                No                       No                         Yes                        *Pseudomonas aeruginosa, Proteus mirabilis* ESBL(+)           May 2017
  8    78            Male     11                    30                      Yes        Yes      Severe                       HT, CHF, CVE        Yes               Yes                      No                         Yes                        *Morganella morganii*                                         May 2017
  9    82            Female   20                    12                      Yes        No       Mild                         HT                  No                No                       No                         Yes                        Negative                                                      May 2017
  10   64            Female   14                    7                       Yes        Yes      Severe                       HT                  No                No                       No                         Yes                        *Staphylococcus aureus*                                       July 2016
  11   77            Female   25                    60                      Yes        Yes      Severe                       HT                  No                No                       No                         Yes                        *Pseudomonas aeruginosa*                                      May 2017
  12   63            Male     12                    85                      Yes        No       Moderate                     PAD, HT             No                No                       No                         Yes                        Negative                                                      May 2017
  13   59            Male     10                    20                      Yes        Yes      Severe                       CAD                 No                No                       Yes                        Yes                        Negative                                                      May 2017
  14   70            Female   10                    30                      Yes        No       Moderate                     CAD, PAD            No                No                       Yes                        Yes                        *Morganella morganii* ESBL(+)                                 June 2017
  15   66            Male     15                    40                      Yes        No       Mild                         --                  No                No                       No                         Yes                        Negative                                                      June 2017
  16   74            Male     27                    80                      Yes        No       Moderate                     HT, CAD, PAD        No                No                       No                         Yes                        *Stenotrophomonas maltophilia, Morganella morganii* ESBL(+)   June 2017
  17   64            Female   4                     30                      Yes        Yes      Severe                       CRF, HT, Cataract   No                No                       Yes                        Yes                        *Pseudomonas aeruginosa*                                      July 2017
  18   53            Male     10                    15                      Yes        Yes      Severe                       CRF, PAD, HT        No                No                       Yes                        Yes                        Negative                                                      July 2017

CAD, coronary artery disease; CRF, chronic renal failure; CVE, central vascular event; DM, diabetes mellitus; ESBL, extended-spectrum beta lactamase; HT, hypertension; IDSA, Infectious Diseases Society of America score; PEDIS, Perfusion, Extent, Depth, Infection And Sensation Score; RA, rheumatoid arthritis; PAD, peripheral artery disease.
